Looking Into The Future of Dementia – Causes and Treatments

Advertisement.

Lori La Bey welcomes back Sharon L. Rogers, the CEO of AmyriAD Therapeutics. Sharon was previously chief of research at Eisai, where she played a leading role in developing Aricept, the top-selling Alzheimer’s medication on the market.

In This Alzheimer’s Speaks Episode, You Will Learn:

Looking Into The Future of Dementia - Causes and Treatments

Who is really funding early-stage trials?
What is the difference between Pharma and Social Therapies?
Do we know how many forms of dementia there are?
What does having a complex dementia mean?
Does a change in diagnosis affect a clinical trial?
About the Domino’s Study.
Will there be a silver bullet medication for dementia in the near future?

Connect with Alzheimer’s Speaks

Visit Alzheimer’s Speaks: www.AlzheimersSpeaks.com

Advertisement.

Find Alzheimer’s Disease and dementia resources.

Listen to More Alzheimer’s Speaks Episodes

Originally published October 26, 2023

Lori La Bey

Lori La Bey is a passionate and inspiring keynote speaker and the founder of Alzheimer’s Speaks, a Minnesota-based advocacy group and media outlet making an international impact by providing education and support for those dealing with Alzheimer’s disease and other dementias.